NPS PHARMACEUTICALS INC Research and Development Expense
NPS PHARMACEUTICALS INC reported Research and Development Expense of $90.11 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-02-18.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2015-02-18
- NPS PHARMACEUTICALS INC research and development expense for the quarter ending 2014-12-31 was $23.87M, a 19.12% increase year-over-year.
- NPS PHARMACEUTICALS INC research and development expense for the quarter ending 2014-09-30 was $24.53M, a 30.49% increase year-over-year.
- NPS PHARMACEUTICALS INC research and development expense for the quarter ending 2014-06-30 was $21.15M, a 31.52% decline year-over-year.
- NPS PHARMACEUTICALS INC research and development expense for the quarter ending 2014-03-31 was $20.56M, a 30.98% increase year-over-year.
- NPS PHARMACEUTICALS INC research and development expense for fiscal 2014 was $90.11M, a 5.49% increase from fiscal 2013.
- NPS PHARMACEUTICALS INC research and development expense for fiscal 2013 was $85.42M, a 9.93% decline from fiscal 2012.
- NPS PHARMACEUTICALS INC research and development expense for fiscal 2012 was $94.84M, a 28.45% increase from fiscal 2011.
- NPS PHARMACEUTICALS INC research and development expense for fiscal 2011 was $73.83M, a 21.40% increase from fiscal 2010.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2014-12-31 | $23.87M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18 | $48.40M derived: sum of 2 quarters · filed 2015-02-18 | $69.55M derived: sum of 3 quarters · filed 2015-02-18 | $90.11M 10-K · filed 2015-02-18 |
| 2014-09-30 | $24.53M 10-Q · filed 2014-11-10 | $45.68M derived: sum of 2 quarters · filed 2014-11-10 | $66.24M 10-Q · filed 2014-11-10 | $86.28M derived: sum of 4 quarters · filed 2015-02-18 |
| 2014-06-30 | $21.15M 10-Q · filed 2014-08-06 | $41.71M 10-Q · filed 2014-08-06 | $61.75M derived: sum of 3 quarters · filed 2015-02-18 | $80.55M derived: sum of 4 quarters · filed 2015-02-18 |
| 2014-03-31 | $20.56M 10-Q · filed 2014-05-08 | $40.60M derived: sum of 2 quarters · filed 2015-02-18 | $59.40M derived: sum of 3 quarters · filed 2015-02-18 | $90.28M derived: sum of 4 quarters · filed 2015-02-18 |
| 2013-12-31 | $20.04M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18 | $38.84M derived: sum of 2 quarters · filed 2015-02-18 | $69.73M derived: sum of 3 quarters · filed 2015-02-18 | $85.42M 10-K · filed 2015-02-18 |
| 2013-09-30 | $18.80M 10-Q · filed 2014-11-10 | $49.69M derived: sum of 2 quarters · filed 2014-11-10 | $65.38M 10-Q · filed 2014-11-10 | $89.42M derived: sum of 4 quarters · filed 2015-02-18 |
| 2013-06-30 | $30.89M 10-Q · filed 2014-08-06 | $46.58M 10-Q · filed 2014-08-06 | $70.63M derived: sum of 3 quarters · filed 2015-02-18 | $88.58M derived: sum of 4 quarters · filed 2015-02-18 |
| 2013-03-31 | $15.70M 10-Q · filed 2014-05-08 | $39.74M derived: sum of 2 quarters · filed 2015-02-18 | $57.69M derived: sum of 3 quarters · filed 2015-02-18 | $90.33M derived: sum of 4 quarters · filed 2015-02-18 |
| 2012-12-31 | $24.04M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18 | $42.00M derived: sum of 2 quarters · filed 2015-02-18 | $74.64M derived: sum of 3 quarters · filed 2015-02-18 | $94.84M 10-K · filed 2015-02-18 |
| 2012-09-30 | $17.96M 10-Q · filed 2013-11-06 | $50.60M derived: sum of 2 quarters · filed 2013-11-06 | $70.80M 10-Q · filed 2013-11-06 | $92.36M derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-06-30 | $32.64M 10-Q · filed 2013-08-08 | $52.84M 10-Q · filed 2013-08-08 | $74.40M derived: sum of 3 quarters · filed 2014-02-18 | $94.63M derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-03-31 | $20.20M 10-Q · filed 2013-05-09 | $41.76M derived: sum of 2 quarters · filed 2014-02-18 | $61.99M derived: sum of 3 quarters · filed 2014-02-18 | $79.13M derived: sum of 4 quarters · filed 2014-02-18 |
| 2011-12-31 | $21.56M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18 | $41.79M derived: sum of 2 quarters · filed 2014-02-18 | $58.93M derived: sum of 3 quarters · filed 2014-02-18 | $73.83M 10-K · filed 2014-02-18 |
| 2011-09-30 | $20.23M 10-Q · filed 2012-11-09 | $37.36M derived: sum of 2 quarters · filed 2012-11-09 | $52.27M 10-Q · filed 2012-11-09 | $68.41M derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-06-30 | $17.14M 10-Q · filed 2012-08-01 | $32.04M 10-Q · filed 2012-08-01 | $48.18M derived: sum of 3 quarters · filed 2013-02-21 | $67.55M derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-03-31 | $14.90M 10-Q · filed 2012-05-03 | $31.05M derived: sum of 2 quarters · filed 2013-02-21 | $50.41M derived: sum of 3 quarters · filed 2013-02-21 | $66.21M derived: sum of 4 quarters · filed 2013-02-21 |
| 2010-12-31 | $16.14M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $35.51M derived: sum of 2 quarters · filed 2013-02-21 | $51.31M derived: sum of 3 quarters · filed 2013-02-21 | $60.81M 10-K · filed 2013-02-21 |
| 2010-09-30 | $19.36M 10-Q · filed 2011-11-03 | $35.16M derived: sum of 2 quarters · filed 2011-11-03 | $44.67M 10-Q · filed 2011-11-03 | |
| 2010-06-30 | $15.80M 10-Q · filed 2011-08-02 | $25.31M 10-Q · filed 2011-08-02 | ||
| 2009-12-31 | $35.34M 10-K · filed 2012-02-15 |